Showing results (281-290 of 473) with videos related to
Sort By:
Pageof 48
Clinical Rehabilitation|September 29, 2006
Is goal planning in rehabilitation effective? A systematic reviewWilliam M M Levack, Kathryn Taylor, Richard J Siegert, et al.Biochemical and Biophysical Research Communications|March 10, 2001
Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 culturesH S Kim, L Liang, R G Dean, et al.Current Hypertension Reports|November 22, 2001
Evidence for cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in diseaseE Kubota, R G Dean, R A Hubner, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 20, 2002
Multiple sclerosis in Malta in 1999: an updateG Dean, M Elian, A Galea de Bono, et al.Veterinary Immunology and Immunopathology|March 4, 2014
Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boostingG Dean, D Clifford, S Gilbert, et al.Neurology|May 5, 1998
Regional cerebral blood flow and language dominance: SPECT during intracarotid amobarbital testingD McMackin, M Jones-Gotman, F Dubeau, et al.Transplantation|August 7, 2016
Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI KidneysColleen L Jay, Kenneth Washburn, Patrick G Dean, et al.Clinical Science (London, England : 1979)|May 14, 2003
Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the ratEiji Kubota, Rachael G Dean, Richard A Hubner, et al.The Cochrane Database of Systematic Reviews|August 19, 2015
Home-based versus centre-based cardiac rehabilitationRod S Taylor, Hayes Dalal, Kate Jolly, et al.Public Health Reports (Washington, D.C. : 1974)|January 1, 1992
The role of data-driven planning and coalition development in preventing cardiovascular diseaseR C Brownson, C A Smith, N E Jorge, et al.Pageof 48